People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kyttaro Ltd | — | Biotechnology | Seed | $5.2M | $45.5M | 2021 |
| CAMBRIDGE SCIENCE Corp | — | Biotechnology | Seed | $3.2M | $98.3M | 2018 |
DOUGLAS EBY at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside DOUGLAS EBY on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alan Ashworth | 1 | 2 |
| JAMES WINSCHEL | 1 | 2 |
| CHAS BOUNTRA | 1 | 1 |
| WILLIAM STOVIN | 1 | 1 |
| AKIKO MIKUMO | 1 | 1 |
| GARY STEINBERG | 1 | 1 |
| ROBERT WILDMAN | 1 | 1 |
| IRENE CHONG | 1 | 1 |
| ARKADIY CHAPKO | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.